Matthias Friedrich
University of Basel(CH)University Hospital of Basel(CH)University of Oxford(GB)Institute of Rheumatology(CZ)Kennedy Center(DK)Oxford BioMedica (United Kingdom)(GB)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand(2002)1,736 cited
- → Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease(2017)772 cited
- → Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease(2019)726 cited
- → Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment(2013)296 cited
- → IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies(2021)270 cited
- → TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions